Evans et al. [12] in UK between 1985 and 2010, considered whether CPM improves overall survival, and found 5.7% occult cancer in 105 women with BRCA1/2 mutations and unilateral breast cancer who underwent CPM. The gene discussed is BRCA1; the disease is breast carcinoma.